CCM
Compton Capital Management Portfolio holdings
AUM
$4.32M
Turnover
83.33%
1-Year Est. Return
27.38%
This Fund
S&P 500
This Quarter
Est. Return
+0.62%
1 Year Est. Return
+27.38%
3 Year Est. Return
+75.57%
5 Year Est. Return
+123.58%
10 Year Est. Return
+303.58%
AUM
$179M
AUM Growth
+$945K
(+0.53%)
Cap. Flow
+$1.2M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
32.28%
Holding
148
New
6
Increased
38
Reduced
74
Closed
5
Avg Time Held
2.5
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.75M |
| 2 |
L3Harris
LHX
|
+$1.07M |
| 3 |
Amazon
AMZN
|
+$566K |
| 4 |
STJ
St Jude Medical
STJ
|
+$544K |
| 5 |
Anadarko Petroleum
APC
|
+$210K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JAH
JARDEN CORPORATION
JAH
|
+$745K |
| 2 |
Under Armour
UAA
|
+$314K |
| 3 |
Lowe's Companies
LOW
|
+$275K |
| 4 |
Agilent Technologies
A
|
+$216K |
| 5 |
Whirlpool
WHR
|
+$214K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.13% |
| 2 | Technology | 15.51% |
| 3 | Financials | 12.68% |
| 4 | Industrials | 12.28% |
| 5 | Communication Services | 10.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.01T
| $10.6M | 5.92% |
443,056
-6,508
| -1% | -$162K |
2013 Q2
12 quarters
|
|
2
ExxonMobil
XOM
$728B
| $6.83M | 3.81% |
72,810
+1,833
| +3% | +$162K |
2013 Q2
12 quarters
|
|
3
GE Aerospace
GE
$319B
| $6.31M | 3.53% |
41,826
-760
| -2% | -$111K |
2013 Q2
12 quarters
|
|
4
Cisco
CSCO
$448B
| $6.04M | 3.38% |
210,679
+1,245
| +0.6% | +$34.9K |
2013 Q2
12 quarters
|
|
5
Gilead Sciences
GILD
$190B
| $5.52M | 3.09% |
66,210
-755
| -1% | -$67K |
2013 Q2
12 quarters
|
|
6
JPMorgan Chase
JPM
$890B
| $5.33M | 2.98% |
85,841
-1,203
| -1% | -$75.1K |
2013 Q2
12 quarters
|
|
7
Invesco Preferred ETF
PGX
$3.6B
| $4.94M | 2.76% |
323,950
-7,000
| -2% | -$105K |
2013 Q2
12 quarters
|
|
8
Nike
NKE
$52.4B
| $4.24M | 2.37% |
76,773
+775
| +1% | +$44.2K |
2013 Q2
12 quarters
|
|
9
Verizon
VZ
$185B
| $4.1M | 2.29% |
73,495
-2,412
| -3% | -$125K |
2013 Q2
12 quarters
|
|
10
Alphabet (Google) Class C
GOOG
$4.2T
| $3.85M | 2.15% |
111,400
-400
| -0.4% | -$14.4K |
2013 Q2
12 quarters
|
|
11
Procter & Gamble
PG
$364B
| $3.33M | 1.86% |
39,297
+268
| +0.7% | +$22K |
2013 Q2
12 quarters
|
|
12
PepsiCo
PEP
$176B
| $3.18M | 1.78% |
30,028
-775
| -3% | -$80K |
2013 Q2
12 quarters
|
|
|
13
Lowe's Companies
LOW
$106B
| $3.02M | 1.69% |
38,096
-3,550
| -9% | -$275K |
2013 Q2
12 quarters
|
|
14
Johnson & Johnson
JNJ
$612B
| $3M | 1.67% |
24,704
-190
| -0.8% | -$21.6K |
2013 Q2
12 quarters
|
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $2.91M | 1.63% |
29,545
-300
| -1% | -$31K |
2013 Q2
12 quarters
|
|
16
Microsoft
MSFT
$3.96T
| $2.79M | 1.56% |
54,596
-200
| -0.4% | -$10.4K |
2013 Q2
12 quarters
|
|
17
CVS Health
CVS
$116B
| $2.69M | 1.5% |
28,128
-780
| -3% | -$77.7K |
2013 Q2
12 quarters
|
|
18
Thermo Fisher Scientific
TMO
$249B
| $2.65M | 1.48% |
17,967
+180
| +1% | +$26.6K |
2013 Q2
12 quarters
|
|
19
AT&T
T
$158B
| $2.63M | 1.47% |
80,710
-6,156
| -7% | -$183K |
2013 Q2
12 quarters
|
|
20
3M
MMM
$84.8B
| $2.6M | 1.45% |
17,724
+1,190
| +7% | +$168K |
2013 Q2
12 quarters
|
|
21
Medtronic
MDT
$121B
| $2.38M | 1.33% |
27,398
-403
| -1% | -$32.6K |
2013 Q2
12 quarters
|
|
22
Bristol-Myers Squibb
BMY
$121B
| $2.36M | 1.32% |
32,094
-910
| -3% | -$64.3K |
2013 Q2
12 quarters
|
|
23
Alphabet (Google) Class A
GOOGL
$4.25T
| $2.34M | 1.31% |
66,560
+1,440
| +2% | +$52.8K |
2015 Q4
2 quarters
|
|
24
Wells Fargo
WFC
$243B
| $2.29M | 1.28% |
48,320
+400
| +0.8% | +$19.5K |
2013 Q2
12 quarters
|
|
25
Berkshire Hathaway Class B
BRK.B
$1.13T
| $2.2M | 1.23% |
15,199
-100
| -0.7% | -$14.3K |
2013 Q2
12 quarters
|
|
Similar funds
GPCM
MAM
BGCI
CAM
EAM
SM
TPL
RC
Compton Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Compton Capital Management held 148 positions worth $179M, up 0.53% from $178M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Compton Capital Management's Q2 2016 filing shows 6 new, 38 increased, 74 reduced and 5 closed positions. Its largest new stake was L3Harris: 13,513 shares worth $1.13M. The largest sale was JARDEN CORPORATION, an estimated $745K.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Compton Capital Management's largest Q2 2016 buy was L3Harris: 13,513 shares worth $1.13M.
- Compton Capital Management added most to Allergan plc in Q2 2016, an estimated $1.75M increase.
- Compton Capital Management's biggest Q2 2016 reduction was Lowe's Companies, cutting an estimated $275K.
- Compton Capital Management fully exited JARDEN CORPORATION in Q2 2016, selling an estimated $745K.
- Compton Capital Management's ten largest holdings make up 32% of its $179M portfolio in Q2 2016.
- Compton Capital Management opened 6 new positions and closed 5 in Q2 2016.
- Compton Capital Management's portfolio value rose 0.53% quarter-over-quarter to $179M.
Based on Compton Capital Management's 13F filing for Q2 2016, filed 8 Aug 2016.